Facebook
Twitter
LinkedIn
Forward3rd Annual Opioid Use Disorder Conference
Overview
Friday, April 11, 2025 at Kleberg Auditorium
One Baylor Plaza, Houston, Texas, 77030
In-person Conference, Virtual Option
NEEDS STATEMENT
The opioid use epidemic has been at the forefront of societal concerns in the United States. The DEA-MATE act requires all providers to adeptly prescribe and manage Opioid Use Disorder (OUD) and related issues. Treating teams face multiple challenges, including treating chronic pain, preventing over-prescription of opioids, and addressing illicit use. This conference will provide education on evidence-based treatment techniques, including pharmacologic and psychotherapeutic approaches, to manage OUD. Attendees will learn to recognize barriers to accessing medication, apply person-first language, and identify signs and symptoms of opioid use disorder and withdrawal. Additionally, attendees will gain knowledge on how to refer patients to appropriate resources for outpatient care, ultimately empowering them to initiate and/or maintain effective treatments for OUD with confidence.
TARGET AUDIENCE
This activity is for physicians and advanced-practice providers in psychiatry, emergency medicine, family medicine, internal medicine, and obstetrics and gynecology and the community.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participants should be able to:
- Apply treatment techniques, including pharmacologic and psychotherapeutic approaches, in managing Opioid Use Disorder.
- Recognize barriers to accessing medication in treatment of Opioid Use Disorder treatment.
- Recall and apply person first language, emphasizing the individual rather than the diagnosis, when interacting with patients diagnosed with Opioid Use Disorder.
- Identify and appropriately respond to signs and symptoms of opioid use disorder and opioid withdrawal.
EDUCATIONAL METHODS
Lecture, Case Study, Small Group Breakout Session, Other: Qualtrics Survey
EVALUATION
Evaluation by questionnaire will address program content, presentation, and possible bias.
ACTIVITY COORDINATOR
Michèle Haykal, MD
michele.haykal@bcm.edu
Venue
Accreditation
Physician
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Ethics
The presentations, The Scope of OUD Treatment in the County; Intersection between Hepatitis C and Opioid Use Disorder Nationally and Locally at Harris Health; How UTH Heroes is Responding to the Opioid Crisis in Houston and Across the State; have been designated by Baylor College of Medicine for 2.00 credit of education in medical ethics and/or professional responsibility.
Pain Management and the Prescription of Opioids
The presentations, The Scope of OUD Treatment in the County; Intersection between Hepatitis C and Opioid Use Disorder Nationally and Locally at Harris Health; How UTH Heroes is Responding to the Opioid Crisis in Houston and Across the State; Managing Opioid Withdrawal in the Emergency Department: ED-Initiated Buprenorphine; What do buprenorphine levels really tell us? Quantitative Analyses in Relation to Clinical Response; Technology Advances in Substance Use Treatment; Stimulant Use Disorder with OUD; SAMSHA Regional Perspective; Santa Maria Hostel: Providing Community-Based, Specialized SUD Treatment for Women and their Families; ADHD, Opioids, and the Family: Protecting Vulnerable Youth; Implementation of a Tobacco-Free Workplace Program in Opioid Treatment Centers in Texas: Findings and Future Directions; Benzos/Gabapentinoids and OUD; have been designated by Baylor College of Medicine for 6.00 credit of education in pain management and the prescription of opioids.
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Attendance
- 2.00 Ethics
- 6.00 Pain Management